Health inspection·November 7, 2024

F 0609 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Few Timely report suspected abuse, neglect, or theft and report the results of the investigation to proper authorities. Based on record review, staff interview, review of the State of Ohio Gateway system, and facility policy review, the facility failed to timely report possible misappropriation of narcotic medications to the appropriate state agency. This affected two residents (#83 and #106) of three residents reviewed for misappropriation of narcotic medications and had the potential to affect 33 additional residents (#1, #4, #7, #8, #13, #17 #18, #15, #21, #23, #24, #27, #33, #34, #36, #38, #39, #40, #45, #46, #48, #49, #50, #70, #72, #77, #79, #80, #88, #90, #93, #96, and #99) identified as being on narcotic medications. The facility census was 104. Findings include: 1. Review of the medical record for Resident #83 revealed an admission date of 09/07/24. Significant diagnoses included altered mental status, presence of left artificial knee joint, and arthritis of unspecified cite. Significant orders included tramadol 50 milligrams (mg) (opioid pain medication) one tablet every 12 hours as needed for pain. A review of the medication administration record (MAR) and the controlled drug disposition form for Resident #83 dated 09/01/24 through 09/30/24 revealed the following discrepancies: • On 09/02/24 at 7:00 A.M. one 50 mg tramadol tablet was signed out on the controlled drug disposition form by Licensed Practical Nurse (LPN) #420. There was no documented evidence on the MAR that the tramadol was administered. • On 09/05/24 at 7:10 A.M. one 50 mg tramadol tablet was signed out on the controlled drug disposition form by LPN #420. There was no documented evidence on the MAR that the tramadol was administered. • On 09/08/24 at 7:00 A.M. three 50 mg tramadol tablets were signed out on the controlled drug disposition form by LPN #420. There was no documented evidence on the MAR that the tramadol was administered. • (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 7 Event ID: 366195 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 366195 B. Wing A. Building (X3) DATE SURVEY COMPLETED 11/07/2024 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Beeghly Oaks Center for Rehabilitation & Healing 6505 Market Street Youngstown, OH 44512 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)